NCCN Risk Reclassification in Black Men with Low and Intermediate Risk Prostate Cancer After Genomic Testing.
Seiden B, Weng S, Sun N, Gordon D, Harris WN, Barnett J, Myrie A, Jones T, Pak SY, Fudl A, Shields J, McNeil BK, Weiss JP, Smith MT, Esdaille AR, Winer AG.
Seiden B, et al. Among authors: winer ag.
Urology. 2022 May;163:81-89. doi: 10.1016/j.urology.2021.08.055. Epub 2021 Oct 22.
Urology. 2022.
PMID: 34688772